aspect of
drug)
→
ReceivesAction
→
observed in study
| Typicality: | 0.493 |
| Saliency: | 0.448 |
| always | 5 | temporal |
| on humans | 4 | transitive-object |
| in practice | 2 | other |
| effect → be observed in → study | 8 |
| effect → be reported in → study | 7 |
| effect → be documented in → study | 7 |
| effect → be seen in → the study | 4 |
| effect → be noted in → study | 4 |
| effect → be found in → study | 3 |
| effect → be observed in → this study | 3 |
| effect → occur in → study | 3 |
| effect → be examined in → this study | 3 |
| negative | neutral | positive |
| 0.358 | 0.578 | 0.065 |
| Raw frequency | 42 |
| Normalized frequency | 0.448 |
| Modifier score | 0.662 |
| Perplexity | 99.961 |